SRZN
Price:
$9.2326
Market Cap:
$29.60M
Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. Its products in pipeline include SZN-043 a tissue-specific R-spondin mimetic for the treatment of severe liver disease; and SZN-1326, a bi-specific full-length human antibody that directly modulates Wnt signaling in target tissue by binding to particular Frizzled and LRP receptors that are expressed in intestinal crypts. Sur...[Read more]
Industry
Biotechnology
IPO Date
2021-01-11
Stock Exchange
NASDAQ
Ticker
SRZN
According to Surrozen, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.43. This represents a change of -6.12% compared to the average of -0.46 of the last 4 quarters.
The mean historical PE Ratio of Surrozen, Inc. over the last ten years is -2.32. The current -0.43 PE Ratio has changed 1.75% with respect to the historical average. Over the past ten years (40 quarters), SRZN's PE Ratio was at its highest in in the December 2022 quarter at 0.60. The PE Ratio was at its lowest in in the March 2022 quarter at -280.88.
Average
-2.32
Median
-2.45
Minimum
-4.30
Maximum
-0.44
Discovering the peaks and valleys of Surrozen, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 51.05%
Maximum Annual PE Ratio = -0.44
Minimum Annual Increase = -83.01%
Minimum Annual PE Ratio = -4.30
Year | PE Ratio | Change |
---|---|---|
2023 | -0.44 | -39.65% |
2022 | -0.73 | -83.01% |
2021 | -4.30 | 16.19% |
2020 | -3.70 | 51.05% |
The current PE Ratio of Surrozen, Inc. (SRZN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.82
5-year avg
-2.32
10-year avg
-2.32
Surrozen, Inc.’s PE Ratio is less than Bolt Biotherapeutics, Inc. (-0.37), greater than Larimar Therapeutics, Inc. (-8.80), greater than Keros Therapeutics, Inc. (-11.28), less than Kezar Life Sciences, Inc. (-0.41), less than Processa Pharmaceuticals, Inc. (-0.37), less than NexImmune, Inc. (-0.00), less than Evelo Biosciences, Inc. (-0.00), greater than Tempest Therapeutics, Inc. (-0.88), greater than Replimune Group, Inc. (-3.26), greater than Nuvectis Pharma, Inc. (-4.95), less than Lyra Therapeutics, Inc. (-0.18), greater than Kronos Bio, Inc. (-0.58), greater than Gossamer Bio, Inc. (-2.55), less than ERYTECH Pharma S.A. (27.34), greater than Aptorum Group Limited (-5.54), greater than Unicycive Therapeutics, Inc. (-0.46), greater than Armata Pharmaceuticals, Inc. (-1.26), less than CytomX Therapeutics, Inc. (9.19), greater than Instil Bio, Inc. (-0.78), greater than Neoleukin Therapeutics, Inc. (-0.98), less than Spero Therapeutics, Inc. (4.06), greater than Assembly Biosciences, Inc. (-2.10),
Company | PE Ratio | Market cap |
---|---|---|
-0.37 | $24.78M | |
-8.80 | $513.64M | |
-11.28 | $1.97B | |
-0.41 | $40.82M | |
-0.37 | $4.17M | |
-0.00 | $711.28K | |
-0.00 | $1.90K | |
-0.88 | $31.26M | |
-3.26 | $708.49M | |
-4.95 | $115.27M | |
-0.18 | $17.85M | |
-0.58 | $59.36M | |
-2.55 | $205.87M | |
27.34 | $47.38M | |
-5.54 | $15.65M | |
-0.46 | $33.41M | |
-1.26 | $84.31M | |
9.19 | $93.74M | |
-0.78 | $92.68M | |
-0.98 | $8.20M | |
4.06 | $71.07M | |
-2.10 | $107.81M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Surrozen, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Surrozen, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Surrozen, Inc.'s PE Ratio?
How is the PE Ratio calculated for Surrozen, Inc. (SRZN)?
What is the highest PE Ratio for Surrozen, Inc. (SRZN)?
What is the 3-year average PE Ratio for Surrozen, Inc. (SRZN)?
What is the 5-year average PE Ratio for Surrozen, Inc. (SRZN)?
How does the current PE Ratio for Surrozen, Inc. (SRZN) compare to its historical average?